Ogsiveo And Winrevair Among Latest Orphan Drugs To Secure Early Access Funding In France

 
• By Francesca Bruce
  
Several orphan drugs will receive swifter reimbursement through France's early access mechanism

More from Health Technology Assessment

More from Geography